NHS and falsified medicines top priorities of new Board Kyriakos Mikellis, Cyprus Business Manager at Pfizer, has been re-elected president of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) for another two year term. In statements,...
KEFEA: Aim is to boost credibility at European level Transfers of value made by pharmaceutical companies involving the expenses incurred in relation to healthcare professionals and healthcare organisations are to be made public for the first time by the end of June as...
* By Kyriakos Mikellis In most European countries, unlike Cyprus, policies on pharmaceuticals give patients access to the treatment their doctors consider the most appropriate. Pharmaceuticals and pharmaceutical care are usually the responsibility of three independent...
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) is surprised by media reports claiming that 40% of pharmaceutical products at state pharmacies are inadequately labelled. In statements, KEFEA President Kyriacos Mikellis said that “as...
The implementation of a National Health System (NHS) that will guarantee high quality healthcare services as well as other important matters involving the pharmaceutical industry were discussed during the first meeting between Health Minister George Pamborides and the...
